Stuart A Sievers

USPTO Granted Patents = 15 (Patent Applications = 9)

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 14)

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 27(Granted Patents)

Location History:

Van Nuys, CA (US) (2014 - 2023)
Santa Monica, CA (US) (2020 - 2023)

Company Filing History:

University of California

patents

1 out of 2,103

University of Washington

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459979 - Modified chimeric antigen receptors and methods of use (2025-11-04),

2. 12404305 - Chimeric polypeptides and uses thereof (2025-09-02),

3. 12202909 - Antigen binding molecules specific for an anti-CD19 scFV (2025-01-21),

4. 11834654 - Antigen binding molecules and methods of use thereof (2023-12-05),

5. 11820823 - T cell receptor antigen binding molecules and methods of use thereof (2023-11-21),

6. 11793834 - Chimeric antigen and T cell receptors and methods of use (2023-10-24),

7. 11608517 - Antigen binding molecules and methods of use thereof (2023-03-21),

8. 11572388 - Chimeric polypeptides and uses thereof (2023-02-07),

9. 11390655 - Modified chimeric antigen receptors and methods of use (2022-07-19),

10. 11384155 - Antigen binding molecules specific for an anti-CD19 scFv (2022-07-12),

11. 10844371 - Antigen binding molecules and methods of use thereof (2020-11-24),

12. 10844120 - Humanized antigen-binding domains and methods of use (2020-11-24),

13. 10626187 - Antigen binding molecules specific for an anti-CD19 scFv (2020-04-21),

14. 10501775 - Antigen binding molecules and methods of use thereof (2019-12-10),

15. 8754034 - Structure-based design of peptide inhibitors of amyloid fibrillation (2014-06-17),

Title: Exploring the Innovations of Inventor Stuart A. Sievers

Introduction

Stuart A. Sievers is a notable inventor based in Van Nuys, California. With a total of 13 patents to his name, he has made significant contributions to the field of biotechnology, particularly in developing antigen-binding molecules for therapeutic applications.

Latest Patents

Among his most recent innovations is a patent for "Antigen binding molecules specific for an anti-CD19 scFV," which provides isolated antigen-binding molecules that engage with specific sequences. Another noteworthy patent is "Antigen binding molecules and methods of use thereof," offering isolated molecules that bind to various amino acid sequences for potential clinical use. These patents showcase his commitment to advancing medical treatments through innovative approaches.

Career Highlights

Throughout his career, Stuart has worked with prominent companies such as Kite Pharma, Inc. and the University of California. His work at these institutions has allowed him to further his research and development in the field of biotechnology, making a lasting impact on scientific advancements.

Collaborations

Stuart A. Sievers has collaborated with esteemed colleagues including Jed Wiltzius and Jed J.W. Wiltzius. These professional relationships have fostered an environment of innovation and creativity, enabling groundbreaking discoveries in the realm of antigen-binding technologies.

Conclusion

Stuart A. Sievers exemplifies the spirit of innovation in biotechnology through his patents and collaborative efforts. His work holds promise for future advancements in medical therapies, underscoring the vital role of inventors in the development of new technologies that can benefit society.

This text is generated by artificial intelligence and may not be accurate.